About
Drugs targeting hearing disorders
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
316
By Phase
PHASE1: 5PHASE2: 3
By Status
COMPLETED: 8
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05873062Lead Sponsor
Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
PHASE1Completed
6 participants
Started: May 12, 2023 · Completed: May 1, 2024
NCT04158453Lead Sponsor
Safety, Blood Levels and Effects of AUT00201
PHASE1Completed
80 participants
Started: Oct 10, 2019 · Completed: Dec 24, 2020
NCT03164876Lead Sponsor
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
PHASE1Completed
24 participants
Started: Apr 20, 2017 · Completed: Apr 3, 2019
NCT02935725Lead Sponsor
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
PHASE1Completed
22 participants
Started: Oct 31, 2016 · Completed: Nov 30, 2017
NCT02832128Lead Sponsor
Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
PHASE2Completed
15 participants
Started: May 31, 2016 · Completed: Apr 30, 2017
Locations (1)
Headquarters
Stevenage, UK
Map
Loading map...